Researchers from Duke University Medical Center have identified a variation in a particular gene that increases susceptibility to early coronary artery disease. For years, scientists have known that the devastating, early-onset form of the disease was inherited, but they knew little about the gene(s) responsible until now. The results are published January 2 in the
Full Post: Neuropeptide Y gene variation may lead to early coronary artery disease
While doctors are urged to start with a diuretic-based strategy to control patients’ high blood pressure, an international blood pressure study shows a different single-pill drug combination is more effective at preventing heart-related events such as heart attacks and strokes.
The findings challenge the way blood pressure is usually treated worldwide.
The randomized study led by a University of Michigan Health System researcher compared two drug combinations. The results, which appear in today’s New England Journal of Medicine, were so significant that the trial was stopped early.
Both single-pill combination drugs helped more than 75 percent of people who had high blood pressure and other cardiovascular risk factors get their blood pressure down. But even more important, patients in the study taking the combination that included a calcium channel blocker had 20 percent fewer heart-related events than the patients taking the other combination.
In all, 11,506 study participants took a single tablet that includes two medications. One group received a tablet containing benazepril, which is a type of drug called an ACE inhibitor, and amlodipine, which belongs to a class of drugs known as calcium channel blockers or CCBs. The other pill combined benazepril and hydrochloro-thiazide, a type of diuretic or “water pill.” The 20 percent reduction in cardiovascular events was observed with the ACE/CCB combination tablet.
Cardiovascular events were defined as cardiovascular deaths, heart attacks, strokes, hospitalizations for unstable angina and treatments to re-open blocked heart arteries.
Currently, national guidelines for the treatment of high blood pressure (also called hypertension) call for patients who need medication to start out on a single pill, usually a diuretic, or water pill, and to add other drugs only as needed to bring pressure down. But the new results may signal a need to change those guidelines.
The ACCOMPLISH study suggests physicians no longer give diuretics preferred status in treating patients.
“This robust study showed us that switching patients to a single-pill combination meant that twice as many patients got to their blood pressure goal, regardless of previous therapy,” says University of Michigan Health System’s Kenneth Jamerson, M.D., the leader of the study.
“The significant reduction in cardiovascular events we observed in patients will, I hope, show physicians that earlier use of a combination medication, especially with amlodipine, may be in the best interest of patients,” he says.
Jamerson is a professor of internal medicine at the University of Michigan Medical School and a member of the U-M Cardiovascular Center.
Results from the ACCOMPLISH trial show that just six months of treatment with either drug combination was enough to bring the blood pressure of 73 percent of patients into an acceptable range - despite the fact that two-thirds were already taking some other medication before they entered the study. At the beginning of the trial, only 37 percent had blood pressure below 140/90.
However, by the end of the three-year trial blood pressure control rates were 80 percent, with average systolic blood pressure less than 130 mmHg. This represents exceptional blood pressure control when contrasted to the current control rate of about 30 percent in the United States.
Participants from five countries - the United States, Sweden, Norway, Denmark and Finland - were part of the trial, and all patients were at risk for cardiovascular events.
Many studies have already shown that reducing blood pressure can reduce the risk of stroke, heart attack, heart failure and other conditions, but many people have a very difficult time achieving blood pressure control.
As many as 73 million Americans have high blood pressure. But because high blood pressure doesn’t cause symptoms, most people who have it, don’t know it.
Over time, uncontrolled blood pressure affects the blood vessel walls, encouraging the growth of weak spots called aneurysms and the formation of narrowed and inflamed areas that can lead to clots that can break off and cause heart attacks and strokes.
Fortunately, once the condition is diagnosed, doctors have a broad range of medicines to choose from to try to get it under control, including many inexpensive generic medicines.
But studies have found that patients often have trouble taking the multiple medications they need. As a result, many companies have developed combination pills.
The study was funded by Novartis, which is among the companies that offer two-drug combination tablets for blood pressure treatment. ACCOMPLISH stands for Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension.
Authors: In addition to Jamerson, ACCOMPLISH investigators included Michael A. Weber, M.D., George L. Bakris, M.D., Björn Dahlör, M.D., Bertram Pitt, M.D., Victor Shi, M.D., Allen Hester, Ph.D., Jitendra Gupte, M.S., Marjorie Gatlin, M.D. and Eric J. Velazquez, M.D.
http://www.med.umich.edu/
--------------------------------------------------------------------------------------------
Related Posts:
Continuously measuring blood pressure may help predict heart disease and related deaths among individuals with treatment-resistant hypertension, while blood pressure readings taken in a medical office do not appear to predict future heart risks, according to a report in November 24 issue of Archives of Internal Medicine. About 10 percent to 30 percent of individuals
Full Post: Blood pressure readings taken at medical office do not appear to predict future heart risks
Sleeping less than seven and a half hours per day may be associated with future risk of heart disease, according to a report in the November 10 issue of Archives of Internal Medicine. In addition, a combination of little sleep and overnight elevated blood pressure appears to be associated with an increased risk of the
Full Post: Lack of sleep tied to greater risk of heart disease
Individuals who have persistent high blood pressure are at increased risks of a number of serious medical conditions, including heart failure. One of the factors that contributes to such heart failure is thickening of the muscle wall of the heart. Such thickening (known as hypertrophy) is a compensatory response of the heart to the high
Full Post: Molecular insight into how a heart failure drug in clinical trials works
Many patients with cardiovascular disease are not given adequate drug therapy. This is the result of an international study. In the current edition of Deutsches ?zteblatt International ( Dtsch Arztebl Int 2008; 105[45]: 769-75), Uwe Zeimer et al. present the German results of this prospective, one-year survey. 512 doctors in Germany took part in the
Full Post: Heart patients are often not treated in accordance with guidelines
A study published next week in the open access journal PLoS Medicine suggests that elderly people with damaged kidneys are at greater risk of cardiovascular disease, such as heart failure and stroke, and other causes of mortality. The findings indicate that greater efforts should be made to encourage elderly people who have impaired kidney function
Full Post: Impaired kidney function raises risk of heart problems in the elderly --------------------------------------------------------------------------------------------
